Dexcom (DXCM) share buybacks: $500M
Dexcom spent $500M buying back its own shares in the year ended Dec 31, 2025, down 33.3% from $750M a year earlier.
From Dexcom's filings with the SEC · Read the filing · DXCM stock page
Dexcom share buybacks by year
#366 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $500M | -33% |
| Dec 31, 2024 | $750M | +9% |
| Dec 31, 2023 | $689M | +23% |
| Dec 31, 2022 | $558M | – |
Share buybacks of similar companies
Companies in the same industry as Dexcom, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Becton Dickinson | $1B | Sep 30, 2025 |
| Resmed | $700M | Jun 30, 2026 |
| Dexcom | $500M | Dec 31, 2025 |
| Globus Medical | $300M | Dec 31, 2025 |
| Teleflex | $300M | Dec 31, 2025 |
| Inspire Medical Systems | $175M | Dec 31, 2025 |
| Haemonetics | $175M | Mar 28, 2026 |
Questions and answers
What is Dexcom's share buybacks?
Dexcom spent $500M buying back its own shares in the year ended Dec 31, 2025, down 33.3% from $750M a year earlier.
Numbers as reported in Dexcom's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology